RLY-4008
Relay Therapeutics
['focus trial', 'rly-4008', 'refocus trial', 'bcsm', 'solid tumor', 'fgfr2 inhibitor']
excited to see updates on the refocus trial of fgfr2 inhibitor rly-4008 in cholangiocarcinoma and solid tumors! still open at ! #asco23 #hpbcsm #cancerresearch 
GI #Oncologist @ClevelandClinic | @USNews contributor | Tweets my own